During the past decade, Bismarck Cancer Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 59 clinical trials were completed, i.e. on average, 5900% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 6 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bismarck Cancer Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 68 trials, followed by "SWOG Cancer Research Network" with 11 trials sponsored, "National Cancer Institute (NCI)" with 8 trials sponsored, "Eastern Cooperative Oncology Group" with 6 trials sponsored and "NSABP Foundation Inc" with 6 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bismarck Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 97 trials as a collaborator, "NCIC Clinical Trials Group" with 8 trials as a collaborator, "North Central Cancer Treatment Group" with 7 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator and "Eastern Cooperative Oncology Group" with 4 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Bismarck Cancer Center" are "Breast Cancer" (25 trials), "Lung Cancer" (16 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (12 trials), "Lymphoma" (7 trials) and "Colorectal Cancer" (6 trials). Many other conditions were trialed in "Bismarck Cancer Center" in a lesser frequency.

Most popular intervention types in "Bismarck Cancer Center" are "Drug" (89 trials), "Biological" (34 trials), "Other" (30 trials), "Radiation" (21 trials) and "Procedure" (10 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (24 trials), "radiation therapy" (15 trials), "carboplatin" (14 trials), "bevacizumab" (13 trials) and "fluorouracil" (11 trials). Other intervention names were less common.

The vast majority of trials in "Bismarck Cancer Center" are 83 trials for "All" genders, 18 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Bismarck Cancer Center". undefined are not yet recruiting, undefined are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 92 completed trials in Bismarck Cancer Center, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Bismarck Cancer Center, 6 "Phase 1" clinical trials were conducted, 42 "Phase 2" clinical trials and 54 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".